EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Digital pathology and artificial intelligence in breast and gynecologic oncology: from molecular prediction to multimodal integration

Francesca Polit, Hisham F Bahmad, Mohamad B Kassab, Mohamad K Elajami, Monica Recine, Sarah Alghamdi, Robert Poppiti

Frontiers in Oncology · 24.04.2026 · 16

DOI: 10.3389/fonc.2026.1833926 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 24.04.2026. Verfasst von Francesca Polit und 6 weiteren Autor:innen. Beteiligte Einrichtung: Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center of Florida, Miami Beach, FL, United States. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast and gynecologic cancers consist of two groups of complex solid tumors, each with unique genomic features, immune microenvironments, and treatment responses. Recent advances in next-generation sequencing, spatial profiling, and digital pathology have transformed diagnostic methods, enabling seamless integration of morphological and molecular data. Artificial intelligence (AI) and machine learning (ML) are now essential tools for linking histomorphology, immunophenotype, and molecular alterations in ways that were previously unachievable. This review discusses recent progress in integrating digital and molecular pathology for these cancers, with an emphasis on practical clinical applications. We highlight emerging research in breast, endometrial, ovarian, and cervical cancers, where combined image-based and molecular approaches can predict treatment response and survival. Additionally, spatial transcriptomics and proteomics are deepening our understanding of tumor heterogeneity and the interactions between tumor cells, stroma, and immune cells that drive disease progression. We also address current challenges, such as standardization, reproducibility, regulation, and workflow integration, and propose priorities to facilitate the clinical adoption of multimodal data.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencebreast cancerdigital pathologygynecologic oncologymachine learningmolecular pathologymultimodal integrationprecision medicine

Autor:innen und Institutionen

  • Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center of Florida, Miami Beach, FL, United States.
  • Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, United States.
  • Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, United States.
  • Department of Internal Medicine, Hartford Hospital, Hartford, CT, United States.
  • Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.
  • Seymon and Janna Advanced Research Institute at Mount Sinai Medical Center, Miami Beach, FL, United States.

Zitieren

APA

Polit, F., Bahmad, H. F., Kassab, M. B., Elajami, M. K., Recine, M., Alghamdi, S., & Poppiti, R. (2026). Digital pathology and artificial intelligence in breast and gynecologic oncology: from molecular prediction to multimodal integration. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1833926

Vancouver

Polit F, Bahmad HF, Kassab MB, Elajami MK, Recine M, Alghamdi S, et al. Digital pathology and artificial intelligence in breast and gynecologic oncology: from molecular prediction to multimodal integration. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1833926

BibTeX
@article{Polit2026,
  author = {Polit, Francesca and Bahmad, Hisham F and Kassab, Mohamad B and Elajami, Mohamad K and Recine, Monica and Alghamdi, Sarah and Poppiti, Robert},
  title = {Digital pathology and artificial intelligence in breast and gynecologic oncology: from molecular prediction to multimodal integration},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1833926}
}
Kostenlos starten →